U.S. Water Utilities Stock News

NYSE:MRSH
NYSE:MRSHInsurance

Formula 1 Partnership and AI Push Could Be A Game Changer For Marsh & McLennan Companies (MRSH)

In late April 2026, Marsh, a business of Marsh & McLennan Companies, announced a multi-year global partnership with Formula 1 as its first Official Risk Partner and Official Insurance Brokering Partner, alongside prominent trackside branding, curated race experiences, and a new content series on risk decision-making. Around the same time, Oliver Wyman, another Marsh & McLennan business, created senior AI-focused leadership roles to accelerate AI-enabled integration and transformation across...
NasdaqCM:KOPN
NasdaqCM:KOPNSemiconductor

Assessing Kopin (KOPN) Valuation After Major AI And Defense Contract Wins

Recent news around Kopin (KOPN) centers on its partnership with Fabric.AI, including a MicroLED Neural I/o chip program for AI data centers, new development funding, and fresh leadership for this joint effort. See our latest analysis for Kopin. The recent news flow appears to have coincided with sharp share price momentum, with a 30 day share price return of 103.38% and a 90 day share price return of 130.21%. This has contributed to a very strong 1 year total shareholder return of 249.03% and...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Why PTC Therapeutics (PTCT) Is Up 12.5% After Beating Q1 Estimates And Lifting 2026 Guidance

In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of US$866.56 million to a net loss of US$2.81 million while still beating analyst expectations on both revenue and earnings per share. The company also released positive 24-month interim data for Huntington’s disease therapy votoplam and raised its 2026 product revenue guidance, underscoring how a strong Sephience launch and advancing...
NYSE:BRX
NYSE:BRXRetail REITs

A Look At Brixmor Property Group (BRX) Valuation After Q1 2026 Results Guidance Update And Dividend Affirmation

Why Brixmor’s latest update matters for income-focused investors Brixmor Property Group (BRX) combined three key updates on April 27, 2026, releasing first quarter results, revising full year earnings guidance, and affirming its regular cash dividend. For the first quarter of 2026, the company reported sales of US$354.34 million and revenue of US$354.82 million, compared with US$337.24 million and US$337.51 million a year earlier. Net income for the quarter was US$127.75 million, compared...
NYSE:SBSI
NYSE:SBSIBanks

A Look At Southside Bancshares (SBSI) Valuation After Q1 Earnings Growth And Dividend Reaffirmation

Southside Bancshares (SBSI) drew fresh attention after reporting first quarter 2026 results and affirming a quarterly dividend of $0.36 per share, pairing earnings information with a continued cash return to shareholders. See our latest analysis for Southside Bancshares. The recent first quarter update and confirmed dividend come after a steadily improving share price. The 1 month share price return was 5.12% and the year to date share price return was 10.51%, alongside a 1 year total...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Assessing Whether Stagwell (STGW) Remains Undervalued After Recent Share Price Momentum

Stock performance snapshot Stagwell (STGW) has quietly drawn attention after recent trading, with the stock last closing at US$6.46 and showing positive returns over the past week, month, past 3 months, and year to date. See our latest analysis for Stagwell. That recent 0.94% 1 day share price return fits into a stronger trend, with a 24.71% 3 month share price return and 29.33% 1 year total shareholder return suggesting momentum has been building rather than fading. If this kind of move has...
NYSE:EE
NYSE:EEOil and Gas

A Look At Excelerate Energy (EE) Valuation After Recent Share Price Volatility

Why Excelerate Energy is on investors’ radar Excelerate Energy (EE) has drawn fresh attention after recent trading left the stock with a year to date total return of 19.58% and a 1 year total return of 17.62%, against a last close of US$33.89. See our latest analysis for Excelerate Energy. Recent trading has been choppy, with the share price up 2.5% on the day to US$33.89 but down over 13% on a 3 month share price return. This compares with a stronger 3 year total shareholder return of 62.2%,...
NYSE:TMHC
NYSE:TMHCConsumer Durables

A Look At Taylor Morrison Home (TMHC) Valuation After Renewed Analyst Optimism On Earnings And Backlog

Analysts have recently renewed their positive views on Taylor Morrison Home (TMHC) after the homebuilder reported strong earnings, a growing sold backlog, and lower unsold inventory, drawing attention to the stock once again. See our latest analysis for Taylor Morrison Home. The recent analyst interest comes as the stock shows mixed momentum, with a 7 day share price return of 2.42% but a 90 day share price return that fell 9.65%. However, the 5 year total shareholder return of 101.68% points...
NYSE:MAN
NYSE:MANProfessional Services

What ManpowerGroup (MAN)'s Jefferson Wells Sale, Dividend, and Governance Changes Mean For Shareholders

ManpowerGroup recently reported its Q1 2026 results, showing 10.3% revenue growth, significantly higher taxes that reduced net earnings to US$2.5 million, completion of the US$100 million sale of its Jefferson Wells U.S. finance and accounting business, and Board approval of a semi-annual US$0.72 per share dividend payable on June 15, 2026 to shareholders of record on June 1, 2026. Alongside these operational updates, shareholders approved an expanded and extended equity incentive plan and...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

A Look At UFP Technologies (UFPT) Valuation After Q1 2026 Earnings And Acquisition Plans

UFP Technologies (UFPT) just paired its Q1 2026 earnings with a clear push on acquisitions, as management highlighted a full deal pipeline, ongoing bids, and a disciplined filter on price, culture, and fit. See our latest analysis for UFP Technologies. The Q1 2026 earnings update and acquisition commentary have arrived alongside a sharp swing in sentiment, with a 19.7% 7 day share price return and a 14.6% 30 day share price return partly offsetting a 13.8% 90 day decline and leaving the 1...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

Assessing Lincoln Electric (LECO) Valuation After Strong Q1 Earnings And Renewed Investor Interest

Q1 earnings spark fresh interest in Lincoln Electric Holdings (LECO) Lincoln Electric Holdings (LECO) is back on investor radar after reporting first quarter sales of US$1,121.43 million and net income of US$136.38 million, both above the prior year period. See our latest analysis for Lincoln Electric Holdings. The earnings beat comes after a mixed share price run, with the stock up 11.22% year to date and delivering a 40.97% total shareholder return over one year. However, the 90 day share...
NYSE:PLGO
NYSE:PLGOInsurance

Will Dividend Debut and CVC Exit Change Fidelis Insurance Holdings' (FIHL) Ownership and Capital Story?

Fidelis Insurance Holdings Limited recently declared a quarterly dividend of US$0.15 per share, payable on June 26, 2026, following shareholder approval of bye-law amendments and ahead of its rebrand to Pelagos Insurance Capital Limited on May 11, 2026. Alongside this cash return, the company completed the repurchase of all remaining shares held by former principal shareholder CVC Falcon Holdings Limited, simplifying its ownership structure and removing a private equity governance...
NYSE:PRU
NYSE:PRUInsurance

Should Prudential’s ERM Downgrade and Buybacks Reshape How Investors View PRU’s Risk-Return Tradeoff?

In the first quarter of 2026, Prudential Financial, Inc. reported net income of US$597 million, down from US$707 million a year earlier, alongside diluted EPS from continuing operations of US$1.68 versus US$1.96 and completion of a US$248.51 million share repurchase of 2,419,381 shares, or 0.7% of shares outstanding. A.M. Best affirmed Prudential’s A+ Financial Strength Rating and “aa-” Long-Term Issuer Credit Ratings with a stable outlook but reduced its enterprise risk management...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) Is Up 12.1% After PALSONIFY EU Nod And Surging Q1 Revenue Shift

In early May 2026, Crinetics Pharmaceuticals reported first-quarter revenue of about US$10.73 million, up sharply from roughly US$0.36 million a year earlier, alongside a wider net loss of about US$127.85 million and basic loss per share of US$1.23. Shortly before these results, the European Commission approved PALSONIFY (paltusotine) as the first once-daily oral therapy for adult acromegaly across the EU and EEA, reinforcing Crinetics’ shift into a commercial-stage rare disease business...
NasdaqGS:VNET
NasdaqGS:VNETIT

VNET Group (VNET) Is Up 7.8% After Discounted Equity Sale And CFO Exit News – Has The Bull Case Changed?

VNET Group recently announced a US$137.7 million follow-on equity offering at a steep discount and confirmed the past resignation of CFO Qiyu Wang, moves that have raised concerns about shareholder dilution and leadership continuity. The company was also removed from a major investment bank's Asia-Pacific Conviction List, highlighting wavering institutional confidence at a time when its financing choices are under scrutiny. Against this backdrop of discounted equity issuance, we'll now...